Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)
出版年份 2020 全文链接
标题
Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 51, Issue 5, Pages 534-543
出版商
Wiley
发表日期
2020-01-28
DOI
10.1111/apt.15641
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
- (2019) Andrea Sansone et al. Cancers
- Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan
- (2018) Satoshi Shinozaki et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study
- (2017) Takashi Kawai et al. GUT
- Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
- (2017) Yuji Mizokami et al. GUT
- Long-term proton pump inhibitors and risk of gastric cancer development after treatment forHelicobacter pylori: a population-based study
- (2017) Ka Shing Cheung et al. GUT
- Chromogranin As a Biochemical Marker of Neuroendocrine Tumors
- (2016) N. V. Lyubimova et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases
- (2016) Nobuhiro Inatomi et al. PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
- (2015) H. Jenkins et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study
- (2015) Y. Sakurai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
- (2015) L. Lundell et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies
- (2015) S. E. Attwood et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
- (2015) Hirotoshi Echizen CLINICAL PHARMACOKINETICS
- Effect of Timing of Proton Pump Inhibitor Administration on Acid Suppression
- (2015) Kenji Furuta et al. DIGESTION
- Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature
- (2015) Nina Nandy et al. DIGESTIVE DISEASES AND SCIENCES
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
- (2013) Hashem B El-Serag et al. GUT
- Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies
- (2013) Jeong Soo Ahn WORLD JOURNAL OF GASTROENTEROLOGY
- Gastric carcinoids after long-term use of a proton pump inhibitor
- (2012) C. S. Jianu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Twice-Daily Rabeprazole for Reflux Esophagitis Patients Refractory to Standard Once-Daily Administration of PPI: The Japan-Based TWICE Study
- (2012) Yoshikazu Kinoshita et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Burden of Gastro-Oesophageal Reflux Disease in Patients with Persistent and Intense Symptoms Despite Proton Pump Inhibitor Therapy
- (2011) Samira Toghanian et al. CLINICAL DRUG INVESTIGATION
- Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes
- (2011) Seiichi Hayato et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
- (2011) Y. Hori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor
- (2011) Constantin S Jianu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Maintenance Treatment for GERD: Residual Symptoms Are Associated with Psychological Distress
- (2009) A.W. van der Velden et al. DIGESTION
- Changes in gene expression of gastric mucosa during therapeutic acid inhibition
- (2009) Kristin G. Nørsett et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started